01 March 2005 : Original article
Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson DiseaseAlexander M. Goberman
Med Sci Monit 2005; 11(3): CR109-116 :: ID: 15386
Background: Research has found that non-speech motor defi cits in Parkinson Disease (PD) can be consistently improved by levodopa medications and surgical treatment, but that speech and voice are only
partially responsive to treatment. This has led to the assertion that speech is an axial (non-peripheral) feature of PD, along with other features that are only partially responsive to treatment (e.g., postural stability and gait). The current study tested this assertion via examination of the relationship between multiple measures of speech production and multiple measures of non-speech movement in individuals with PD.
Material/Methods: Nine individuals with idiopathic PD were studied, and all participants were taking levodopa-carbidopa medication. Motor performance was examined using the motor portion of the Unifi ed
Parkinson’s Disease Rating Scale, and speech was examined via acoustic analysis of phonation, articulation, and prosody.
Results: Seven of sixteen speech acoustic measures (F[sub]o[/sub]SD in vowels, F2 slope for /u/ and /æ/, F[sub]o[/sub]SD in reading, articulation rate in monologue, and percent pause in reading and monologue) were signifi - cantly correlated with non-speech movements. Results suggested that speech measures are correlated with both axial motor symptoms (e.g., gait, facial expression, posture, postural stability) and
non-axial motor symptoms (e.g., rest tremor, left and right bradykinesia, postural tremor).
Conclusions: It has been hypothesized that axial symptoms of PD are more purely dopaminergic, and non-axial symptoms are related to non-dopaminergic lesions. Therefore, the current results indicate that
certain speech defi cits in PD may result from dopaminergic lesions, while others appear to result from non-dopaminergic lesions.
Keywords: Carbidopa - pharmacology, Carbidopa - therapeutic use, Gait - drug effects, Motor Skills Disorders - complications, Aged, 80 and over, Antiparkinson Agents - therapeutic use, Carbidopa - therapeutic use, Deep Brain Stimulation, Gait - drug effects, Levodopa - therapeutic use, Motor Skills, Motor Skills Disorders - physiopathology, Parkinson Disease - physiopathology, Severity of Illness Index, Speech Acoustics, Time Factors
01 November 2023 : EditorialEditorial: Factors Driving New Variants of SARS-CoV-2, Immune Escape, and Resistance to Antiviral Treatments as the End of the COVID-19 Pandemic is Declared
Med Sci Monit 2023; 29:e942960
28 Nov 2023 : Clinical ResearchImpact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and ...
Med Sci Monit In Press; DOI: 10.12659/MSM.942122
28 Nov 2023 : Clinical ResearchLong-Term Outcomes of Decompression and Grafting in Acute Pathological Proximal Femur Fractures in Children...
Med Sci Monit In Press; DOI: 10.12659/MSM.943031
27 Nov 2023 : Clinical ResearchComparison of Outcomes from Emergency Admissions to a Major Trauma Center in Turkey of 1646 Elderly Patient...
Med Sci Monit In Press; DOI: 10.12659/MSM.942916
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical ResearchPrevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292